Navigation Links
Gene responsible for relapses in young leukemia patients
Date:10/26/2011

This press release is available in French.

One of the causes of resistance to cancer treatment in children is now beginning to be elucidated. Acute lymphoblastic leukemia patients with a particular form of the ATF5 gene are at higher risk of having a relapse when treated with E. coli asparaginase, a key chemotherapy drug for this type of leukemia. This is what a study by Dr. Maja Krajinovic published in the Blood, the journal of the American Society of Hematology, reveals Dr. Krajinovic is an investigator at the Sainte-Justine University Hospital Research Center, which is affiliated with the University of Montreal.

Dr. Krajinovic's team focused on asparaginase, one of the drugs in a chemotherapy "cocktail" administered to young patients during the intensification phase of their treatment.

They observed that E. coli asparaginase therapy was associated with an increase in relapses when administered to patients who had particular polymorphism (special form) of the ATF5 gene. In fact, this gene regulates asparagine synthetase, an enzyme that produces asparagine, which in turn feeds cancer cells.

"In the presence of this polymorphism that, as we demonstrated, modifies the transcription rate of the ATF5 gene, it is possible that the medication, rather than preventing the proliferation of leukemia cells by reducing the rate of asparagine, does just the opposite by creating feedback that triggers cancer cells to produce asparagine themselves," explains Dr. Krajinovic.

The discovery of a form of gene associated with high rates of relapse during treatment with E.coli asparaginase opens the door to the possibility of selecting a type of pharmacological treatment based on a patient's genetic profile, an approach that reflects the shift toward personalized medicine. "If a DNA test detects the implicated polymorphisms in ch
'/>"/>

Contact: William Raillant-Clark
w.raillant-clark@umontreal.ca
514-343-7593
University of Montreal
Source:Eurekalert

Page: 1 2

Related biology news :

1. Scientists identify microbes responsible for consuming natural gas in Deepwater Horizon spill
2. Tick responsible for equine piroplasmosis outbreak identified
3. Competition with humans responsible for decline of New Zealands endangered sea lions, study shows
4. Competition with humans responsible for decline of New Zealands endangered sea lions, study shows
5. Study finds golden algae responsible for killing millions of fish less toxic in sunlight
6. Researchers ID microbe responsible for methane from landfills
7. Gene responsible for severe osteoporosis disorder discovered
8. BUSM researchers uncover cellular mechanism responsible for chronic inflammation, Type 2 diabetes
9. U of M researcher helps unlock 30 new genes responsible for early onset puberty
10. Black aspergilli species responsible for infecting corn identified
11. Researchers find gene responsible for neurodegenerative disease in dogs, possibly in humans
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/10/2014)...     Jifflenow ...   Jifflenow, a leading provider ... business-to-business (B2B) events, today announced a partnership with ... communication (NFC), Bluetooth low energy (BLE), and cloud-based ... Jifflenow will integrate its meeting scheduling ...
(Date:12/5/2014)... -- Tute Genomics, a leader in cloud-based solutions for genome ... led by UK-based Eurovestech. Peak Ventures and a number ... "We are at a pivotal time in ... seeks new approaches for the diagnosis, treatment and prevention ... and CEO of Tute Genomics. "One of the main ...
(Date:12/3/2014)... 2, 2014   Marvin Test Solutions , ... solutions for military, aerospace, and manufacturing organizations, today ... successful TS-900 PXI semiconductor test platform . ... high-end systems to customers at a fraction of ... traditional ATE. "Our semiconductor customers ...
Breaking Biology News(10 mins):Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 2Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 3Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 2Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 3Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 2Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 3
... may do serious harm rather than keep you safe ... a cardiologist at UT Southwestern Medical Center. , Runners ... during a race could put themselves at jeopardy for ... the body's sodium content that can result in physical ...
... biologist at Washington University in St. Louis is giving ... unraveling more clues about our biological clock. , VIP ... (VIP), a neuropeptide originally found in the gut, that ... in the brain. , Erik Herzog, Ph.D., Washington University ...
... UNSW researchers have developed three clones of cells from existing ... treatments for diabetes, Parkinson's disease and spinal cord injury. , ... a very accurate way of extracting and then growing a ... is leading the research and is based at the Diabetes ...
Cached Biology News:Too much water may be as dangerous as too little during long-distance athletic events 2Discovery clarifies role of peptide in biological clock 2Stem cell research - new cell lines 2
(Date:12/17/2014)... 2014 This report is a ... industry. For an overview analysis, the report introduces ... chain structure, industry overview, policy analysis, and news ... has witnessed rapid development with key manufacturers ... This report mentions quartz tubing upstream raw materials ...
(Date:12/17/2014)... 17, 2014 Audacity, a leading California-based ... member of the Huntsworth Health Group, is proud to ... team. In her role, Gonzales will serve as Senior ... incredibly honored to welcome a talent of Jamie’s caliber ... Gaëtan Fraikin. “She is a proven healthcare innovation leader ...
(Date:12/17/2014)... , Dec. 17, 2014 CASI Pharmaceuticals, Inc. ... to the acquisition, development and commercialization of innovative therapeutics ... global market with a primary commercial focus on ... been granted a Type C meeting with the U.S. ... will be held in February 2015.  During this meeting ...
(Date:12/15/2014)... METTLER TOLEDO is pleased to announce that ... with PVM technology , is now available. The ... tool continuously captures high-resolution images under a wide ... prepares a report pairing the most relevant images ... This compelling blend of high resolution images and ...
Breaking Biology Technology:2020 Quartz Tubing Market: Global Development & Forecasts Analysis Now at DeepResearchReports.com 2Audacity Welcomes Healthcare Communications Expert Jamie Gonzales as Senior Vice President of Client Services 2CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 2CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 3CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 4CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 5New Real-Time In Situ Probe-Based Video Microscope from METTLER TOLEDO 2
... The latest in a growing body of shareholder litigation ... dearly. , ,Alleging that members of its management team ... Inc. , a developer of medical imaging and information ... Court. , ,The lawsuits stem from Merge's $325 million ...
... Rights proposal are aiming directly at the heart of ... and municipal governments are necessary to improve Wisconsin's business ... by extension technology investment, in jeopardy. , ,Based in ... development would be handcuffed should the measure be enacted, ...
... biotechnology hot spot will be further enhanced next ... one of the world's premier biotechnology conferences, businesses ... make up 1.5 percent of the total participation ... will be held April 9-12 at Chicago's McCormick ...
Cached Biology Technology:Merge's merger is the crux of shareholder lawsuits 2Critics say tax limits could handcuff tech investment 2Critics say tax limits could handcuff tech investment 3Critics say tax limits could handcuff tech investment 4Critics say tax limits could handcuff tech investment 5Wisconsin to show up at BIO in numbers 2Wisconsin to show up at BIO in numbers 3
... targets including proteins and to their modification ... antigens. A&Gs service is divided into ... 40 days (duration may vary slightly dependent ... I: Immunization, test bleed and fusion; $2,500 ...
... Synthetic peptide derived from the N-terminal ... 17 open reading frame 37 (C17orf37 protein) ... C35 protein. On Western blots it identifies ... Reactivity: Human (positive control: full-length human ...
... Two separate vials containing 200 ... same sequence used as antigens for ... 160890) To be ... cyclase polyclonal antiserum (Catalog No. 160890) ...
Immunogen: Secretory component isolated from human colostrum. Storage: 4 C...
Biology Products: